For patients with advanced breast cancer, NICE has recommended capecitabine should be used on its own, or in combination with another drug, docetaxel, (Taxotere) if the first choice treatment has failed or is unsuitable.
For patients with advanced breast cancer, NICE has recommended capecitabine should be used on its own, or in combination with another drug, docetaxel, (Taxotere) if the first choice treatment has failed or is unsuitable.
对晚期乳腺癌患者，NICE建议如果一线治疗失败或不适宜，卡培他滨应当被单独或联合另一种药物——多西紫杉醇（泰索帝）使用。